Next Article in Journal
Establishment of a Reference Material in Quality Control for Use in Infectivity and Identity Assays of Recombinant COVID-19 Vaccine, in Accordance with International Standards Organization Guidance
Previous Article in Journal
Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine
 
 
Article
Peer-Review Record

Endurance Exercise Does Not Exacerbate Cardiac Inflammation in BALB/c Mice Following mRNA COVID-19 Vaccination

Vaccines 2024, 12(9), 966; https://doi.org/10.3390/vaccines12090966
by Sander Eens 1,2,*, Manon Van Hecke 3, Siel Van den Bogaert 2, Kasper Favere 1,2,4,5, Nathalie Cools 6, Erik Fransen 7, Tania Roskams 3,†, Hein Heidbuchel 1,4,† and Pieter-Jan Guns 2,†
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Vaccines 2024, 12(9), 966; https://doi.org/10.3390/vaccines12090966
Submission received: 16 July 2024 / Revised: 19 August 2024 / Accepted: 21 August 2024 / Published: 26 August 2024
(This article belongs to the Section COVID-19 Vaccines and Vaccination)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

This preclinical study is particularly noteworthy in light of the intense debate surrounding vaccines such as the BNT162b2 mRNA vaccine and the risk of myopericarditis.

The number of experiments conducted is significant, and the methodology is robust. The figures are highly illustrative and well-executed. The cardiac evaluation has been thorough and detailed.

Some minor considerations:

- I would appreciate an exposition in the introduction on how the BNT162b2 mRNA vaccine has also been evaluated using clustering analysis in populations immunomodulated by drugs (it has often been mentioned that physical activity is immunomodulatory) while maintaining a certain level of safety. I recommend a study on a group of pathologies under extensive biological treatment, which has been the subject of much debate. An interesting study to discuss, which I suggest to the authors, is one conducted with the same BNT162b2 mRNA vaccine (https://pubmed.ncbi.nlm.nih.gov/36047032/);

- The paragraph on the analyses is probably somewhat sparse; I would enrich it.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

 

 

The current study titled “Endurance exercise does not exacerbate cardiac inflammation in BALB/c mice following mRNA COVID-19 vaccination” Ref: 3134219, deals with an important subject. Although previous reports discussed this subject mentioning the cardiac inflammation, the present article considered a well-organized methodology for young male mice administrating the vaccinations (two doses of BNT162b2 mRNA) intravenously not intramuscular as usually considered to humans. Minor revisions are needed.

- Although the study is well presented, poor/short discussions for the observations were noticed.

- Body weigh decrease of animals after vaccination should be discussed/explained.

- Animal death (five mice, VEH-SED: n=2, VEH-EEX: n=1, VAX-SED: n=2) after receiving vaccine seems a serious problem for this study.

- The side effects discovered (e,g. hepatic inflammation), that seems a serious issue associated with vaccination, should be discussed and justified.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop